[Infographic] 2018 BDO Biotech Briefing

November 2018

Download Infographic [PDF]

Biotech companies are breaking down silos across their counterparts in healthcare to drive more precise, improved outcomes and shared valued. Couple this with more than 25 patent expirations on the horizon from 2018-19 and the FDA’s heightened focus on encouraging competition, and the result is a boost in research and development (R&D) and bustling deal activity across the industry.
See that and other trends revealed in the 2018 BDO Biotech Briefing.